Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma

National Medical Journal of China

Volumn 87, Issue 33, 2007, Pages 2350-2354

  Wang, Chang Li ^a   Yue, Dong Sheng ^a   Zhang, Zhen Fa ^a   Zhan, Zhong Li ^a   Sun, Lei Na ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Adenocarcinoma, bronchiolo alveolar; Immunohistochemistry; Prognosis; TTF 1

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; THYROID TRANSCRIPTION FACTOR 1;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 37149017634     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jackman DM, Chirieac LR, Janne PA. Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment. Semin Respir Crit Care Med, 2005, 26:342-352.
2. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathologic, 2002, 40:403-439.
3. Lau SK, Desrochers MJ, Luthringer DJ. Expression of thyroid transcription factor-1 , cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinoma: an immunohistochemical evaluation of 67 cases. Mod Pathol, 2002, 15:538-542.
4. Johansson L. Histopathologic classification of lung cancer: relevance of cytokeratin and TTF-1 immunophenotyping. Ann Diagn Pathol, 2004, 8:259-267.
5. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology, 2000, 36:8-16.
6. Chinese source.
7. Shah RN, Badve S, Papreddy K, et al. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Human Pathol, 2002, 33:915-920.
8. Saad RS, Liu YL, Han H, et al. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Human Pathol, 2004, 35:3-7.
9. Berghmans T, Mascaux C, Martin B, et al. Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer. Lung Cancer, 2006, 52:219-224.
10. Haque AK, Syed S, Lele SM, et al. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival. Appl Immunohistochem Mol Morphol, 2002, 10:103-109.
11. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol, 2003, 34: 597-604.
12. Barlesi F, Pinot D, Legoffic A, et al. Positive thyroid transcription factor-1 staining strongly correlates with survival of patients with adenocarcinoma of the lung. Br J Cancer, 2005, 93: 450-452.